logo
ProjectArchived

Tissue Chip Testing Centers: Validating Microphysiological Systems (U24)

Sector: Manufacturing (Industrial) • Location: United States of America

Source: Grants.gov

This Funding Opportunity Announcement (FOA) invites applications for Tissue Chip Testing Center(s) (TCTC) that will provide resources and infrastructure for the validation of tissue chips being developed as part of the NIH Tissue Chip (TC) Program or NIH Microphysiological Systems (MPS) Program. The MPS program supports a consortium of investigators developing accurate cellular and organ microsyst

Status
Closed
Sector
Manufacturing (Industrial), Hospital, Government, Education, Hotel
Location
United States of America
Updated
22 Jul 2026
Source
Grants.gov

ConstructChat

Ask ConstructChat about Tissue Chip Testing Centers: Validating Microphysiological Systems (U24)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Tissue Chip Testing Centers: Validating Microphysiological Systems (U24)” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Participants

Sponsoring Agency

Status

Original status

archived

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

This Funding Opportunity Announcement (FOA) invites applications for Tissue Chip Testing Center(s) (TCTC) that will provide resources and infrastructure for the validation of tissue chips being developed as part of the NIH Tissue Chip (TC) Program or NIH Microphysiological Systems (MPS) Program. The MPS program supports a consortium of investigators developing accurate cellular and organ microsystems representative of human physiology for the evaluation of drug efficacy and toxicity (RFA-RM-11-022).The developed in vitro MPS platforms are representative of major organs and tissues in the human body and need to be validated for their predictive capabilities in the assessment of biomarkers, and the bioavailability, efficacy, and toxicity of therapeutic agents prior to entry into clinical trials.Validation of the tissue chips will be conducted through the TCTC that will be responsible for the testing of a select group of compounds using predefined assays and biomarkers according to pharmaceutical industry standards, and for the integration of the data into a public database.

Location

Country

United States of America (USA)

Source

Source reliability

High

Source

Grants.gov

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Hospital, Government, Education, Hotel

Article published date

2023-06-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project